Published in Chest on April 01, 1999
Mycobacterium avium in the postgenomic era. Clin Microbiol Rev (2007) 2.65
Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis (2010) 2.58
Cavitary pulmonary disease. Clin Microbiol Rev (2008) 2.31
Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci (2005) 2.15
Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis (2009) 1.91
Nontuberculous mycobacterial disease following hot tub exposure. Emerg Infect Dis (2001) 1.81
Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med (2009) 1.36
Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol (2002) 1.34
Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis (2013) 1.31
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis (2013) 1.12
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med (2007) 1.05
Management of nontuberculous mycobacterial infection in the elderly. Eur J Intern Med (2014) 1.04
Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung (2010) 1.01
ATP synthase inhibition of Mycobacterium avium is not bactericidal. Antimicrob Agents Chemother (2009) 0.94
Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc (2014) 0.92
Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerg Infect Dis (2016) 0.89
Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study. PLoS One (2014) 0.82
Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease. Antimicrob Agents Chemother (2015) 0.82
Opinions differ by expertise in Mycobacterium avium complex disease. Ann Am Thorac Soc (2014) 0.79
Detection of Legionella, L. pneumophila and Mycobacterium avium complex (MAC) along potable water distribution pipelines. Int J Environ Res Public Health (2014) 0.79
Bronchiectasis and non-tuberculous mycobacterial pulmonary infection. Thorax (2006) 0.79
Assessment of Prevalence of Non-tuberculous Mycobacteria in Archival Acid-fast Bacilli Positive Smear Slides by TaqMan Real-time PCR Assay. N Am J Med Sci (2012) 0.78
Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures. PLoS One (2017) 0.78
Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections. Clin Vaccine Immunol (2008) 0.77
Non-tuberculous mycobacteria: baseline data from three sites in Papua New Guinea, 2010-2012. Western Pac Surveill Response J (2015) 0.76
Opportunistic Pathogens Mycobacterium Avium Complex (MAC) and Legionella spp. Colonise Model Shower. Pathogens (2015) 0.76
Mycobacterium avium genotype is associated with the therapeutic response to lung infection. Clin Microbiol Infect (2013) 0.76
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. Antimicrob Agents Chemother (2015) 0.76
Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med (2000) 2.30
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem (1984) 2.17
Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues. J Biol Chem (1986) 1.90
Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem (1999) 1.72
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med (2000) 1.59
PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem (1999) 1.50
Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem (2000) 1.49
Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest (1996) 1.46
Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter. J Biol Chem (1994) 1.43
Tick-borne pulmonary disease: update on diagnosis and management. Chest (1999) 1.39
Nuclear factor-90 of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry (1999) 1.33
DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. J Biol Chem (1998) 1.32
Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am J Physiol (1992) 1.14
Indices of hypoxemia in patients with acute respiratory distress syndrome: reliability, validity, and clinical usefulness. Crit Care Med (1997) 1.08
Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings. AJR Am J Roentgenol (2001) 1.08
Potassium currents in freshly dissociated uterine myocytes from nonpregnant and late-pregnant rats. J Gen Physiol (1998) 1.05
Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am J Respir Cell Mol Biol (1995) 1.02
Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.01
NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death Differ (2009) 1.01
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med (2001) 1.01
Mapping the alpha-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J Biol Chem (1990) 0.96
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother (1999) 0.93
Actions of epimers of 12-(OH)-reduced saxitoxin and of 11-(OSO3)-saxitoxin on squid axon. Toxicon (1985) 0.93
Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med (1998) 0.93
Autoantibodies define a family of proteins with conserved double-stranded RNA-binding domains as well as DNA binding activity. J Biol Chem (1999) 0.92
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc (1996) 0.90
CsA-sensitive purine-box transcriptional regulator in bronchial epithelial cells contains NF45, NF90, and Ku. Am J Physiol (1998) 0.88
Leukotriene B4 mediates histamine induction of NF-kappaB and IL-8 in human bronchial epithelial cells. Am J Physiol (1998) 0.88
Functional sites and transient states of the nicotinic acetylcholine receptor. Soc Gen Physiol Ser (1987) 0.87
Diaphragmatic paralysis due to Lyme disease. Eur Respir J (1999) 0.87
The active guanidinium group of saxitoxin and neosaxitoxin identified by the effects of pH on their activities on squid axon. Pflugers Arch (1983) 0.86
Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides. J Heart Lung Transplant (1996) 0.84
Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest (1995) 0.81
Human airway epithelial cells express interleukin-2 in vitro. Am J Physiol (1997) 0.80
Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. Biochem Biophys Res Commun (1997) 0.79
Binding of a curarimimetic toxin from cobra venom to the nicotinic acetylcholine receptor. Interactions of six biotinyltoxin derivatives with receptor and avidin. J Biol Chem (1985) 0.77
Functional domains of the nicotinic acetylcholine receptor. Ann N Y Acad Sci (1986) 0.76
Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase. J Immunol (1992) 0.76
Hazards with both determining and utilizing oxygen consumption measurements in the management of critically ill patients. Crit Care Med (1996) 0.75
Modulation of thrombin and thrombin receptor peptide mitogenicity by human lung mast cell tryptase. Am J Physiol (1994) 0.75
Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide. Clin Exp Immunol (1988) 0.75
Role of suturing and incision in astigmatism following cataract surgery. Indian J Ophthalmol (1988) 0.75
Successful pregnancy and cesarean delivery via noninvasive ventilation in mitochondrial myopathy. J Perinatol (2009) 0.75
Heterogeneity of intact granules purified from canine mastocytoma cell lines. Am J Physiol (1991) 0.75
Dog mastocytoma cells secrete a growth factor for fibroblasts. Am J Respir Cell Mol Biol (1992) 0.75
Thrombin receptor polymorphism in Chinese hamster. Biochem Biophys Res Commun (1995) 0.75
Cellulose granulomatosis presenting as centrilobular nodules: CT and histologic findings. AJR Am J Roentgenol (2001) 0.75
Nasal-pulmonary relations in allergic fungal sinusitis and allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol (2001) 0.75